Phase II trial of oral gimatecan in adults with recurrent glioblastoma

被引：0
|
作者：
Hu, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Wen, P. Y. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Abrey, L. E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Fadul, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Drappatz, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Salem, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Amato, A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Carminati, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Supko, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Hochberg, F. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02114 USA
[2] Brigham & Womens Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[5] Sigma Tau Res Inc, Gaithersburg, MD USA
[6] Sigma Tau Ind Farmaceut Reiunite SpA, Pomezia, Italy
[7] Harvard Univ, Ctr Canc, Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2009
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma
    Antonio Silvani
    Irene De Simone
    Vittorio Fregoni
    Elena Biagioli
    Enrico Marchioni
    Manuela Caroli
    Andrea Salmaggi
    Andrea Pace
    Valter Torri
    Paola Gaviani
    Erica Quaquarini
    Giorgia Simonetti
    Eliana Rulli
    Maurizio D’Incalci
    Journal of Neuro-Oncology, 2019, 142 : 455 - 462
  • [32] Phase II trial of intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma
    Ursu, R.
    Carpentier, A.
    Metellus, P.
    Barrie, M.
    Meng, Y.
    Laigle-Donadey, F.
    Tibi, A.
    Chinot, O.
    Carpentier, A. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma
    Silvani, Antonio
    De Simone, Irene
    Fregoni, Vittorio
    Biagioli, Elena
    Marchioni, Enrico
    Caroli, Manuela
    Salmaggi, Andrea
    Pace, Andrea
    Torri, Valter
    Gaviani, Paola
    Quaquarini, Erica
    Simonetti, Giorgia
    Rulli, Eliana
    D'Incalci, Maurizio
    Poli, Davide
    Mariotti, Evelina
    Caramia, Grazia
    Gritti, Angela Pesenti
    Pacchetti, Ilaria
    Zucchetti, Massimo
    Lanza, Annalisa
    Basso, Gianpaolo
    Bini, Paola
    Berzero, Giulia
    Diamanti, Luca
    Di Cristofori, Andrea
    Manzoni, Andrea
    Lanfranchi, Giordano
    Ardizzoia, Antonio
    Villani, Veronica
    JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) : 455 - 462
  • [35] PRELIMINARY RESULTS OF A PHASE I/II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA
    Chow, Frances
    Berens, Michael
    Palmer, Joycelynne
    Villalona-Calero, Miguel
    Ney, Douglas
    de la Fuente, Macarena
    Jaeckle, Kurt
    Kizilbash, Sani H.
    Nasany, Ruham Alshiekh
    Hrachova, Maya
    Porter, Alyx B.
    Piccioni, David
    Hoang, Kimberly
    Lipinski, Lindsay
    Strowd, Roy
    Giglio, Pierre
    Mantica, Megan
    Schiff, David
    Gore, Steven
    Portnow, Jana
    NEURO-ONCOLOGY, 2024, 26
  • [36] Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM)
    Friedman, H. S.
    Desjardins, A.
    Vredenburgh, J. J.
    Rich, J. N.
    Sathornsumetee, S.
    Gururangan, S.
    Quinn, J. A.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)
    Reardon, David
    Groves, Morris
    Wen, Patrick
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Harris, Dean
    DeMarini, Douglas
    Suttle, Ben
    Arumugham, Thangam
    Hodge, Jeffrey
    Lager, Joanne
    NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [38] How effective is BCNU in recurrent glioblastoma in the modern era?: A phase II trial
    Brandes, AA
    Tosoni, A
    Amistà, P
    Nicolardi, L
    Grosso, D
    Berti, F
    Ermani, M
    NEUROLOGY, 2004, 63 (07) : 1281 - 1284
  • [39] Phase II trial of irinotecan and thalidomide in adult patients with recurrent glioblastoma multiforme
    Puduvalli, V. K.
    Giglio, P.
    Groves, M. D.
    Hess, K. R.
    Gilbert, M. R.
    Mahankali, S.
    Jackson, E.
    Levin, V. A.
    Conrad, C. A.
    Hsu, S.
    Colman, H.
    Ritterhouse, M.
    Ichtech, S.
    Yung, W. K. A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 450 - 450
  • [40] A PHASE II TRIAL OF SORAFENIB (NEXAVAR) AND PROTRACTED TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839
12345